Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMAC for Severe Hip or Knee Osteoarthritis
NCT03908827Phase 3Withdrawn
- Sponsor
- CAPRI Clinic
- Start
- Dec 2019
- Primary completion
- Dec 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of autologous bone marrow cell concentrate in osteoarthritis (OA) (2 arms), sponsored by CAPRI Clinic. Primary endpoint: Numeric Pain Rating Scale at 12 months. Planned start Dec 2019; status: withdrawn.
02
Drugs
autologous bone marrow cell concentrate
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03908827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03908827.